Drugs / trivalent influenza vaccine (contains B/Victoria strain)
trivalent influenza vaccine (contains B/Victoria strain)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03859141 Comparator | Feb → Apr 2018 | influenza | Sinovac Biotech Co., Ltd | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | trivalent influenza vaccine (contains B/Victoria strain) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03859141 ↗ |
| Modality | Vaccine | “licensed trivalent influenza vaccines (TIVs)” PMID 32347785 ↗ Apr 2020 |